Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Zentek Ltd. (V:ZEN)

Business Focus: Biotechnology & Medical Research (NEC)

Mar 25, 2024 08:00 am ET
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that its C19HBA SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform has shown a promising safety and toxicity profile in preclinical testing. This is a critical step in the path towards the development of a human therapeutic.
Jan 30, 2024 08:13 am ET
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera")has completed testing of its C19HBA aptamer as a potential therapeutic. The SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform successfully outperformed a leading monoclonal antibody ("LMA") in preclinical testing demonstrating potential as a therapeutic for SARS-CoV-2.
Jan 22, 2024 10:00 am ET
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
GUELPH, ON / ACCESSWIRE / January 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce the completion of a new study highlighting the potential significant energy, emission and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters.
Jan 19, 2024 08:45 am ET
Zentek Announces Eric Wallman Appointed as Chairman of the Board
GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that effective January 12th, Dr. Francis Dubé has resigned as Chairman of the Board of the Company in order to appoint an independent director, Mr. Eric Wallman as the Chairman of the Board as per best practices in governance. Mr. Wallman has been an independent director of the Company since 2018 and served as head of the audit commi
Dec 13, 2023 03:30 pm ET
Zentek Launches Triera Biosciences Ltd.
GUELPH, ON / ACCESSWIRE / December 13, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the launch of Triera Biosciences Ltd. (Triera) as Zentek's wholly owned subsidiary for its aptamer platform technology. As announced in the October 5th, 2023, news release, this subsidiary now owns the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University.
Dec 08, 2023 08:15 am ET
Zentek and 1Click Heating and Cooling Sign Distribution Agreement
GUELPH, ON / ACCESSWIRE / December 8, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company and 1Click Heating and Cooling Inc. ("1Click"), a private Heating, Ventilation and Air Conditioning ("HVAC") company focused on the heat pump market are pleased to announce that they have signed a distribution agreement on December 7th, 2023, for an initial 2-year term from the Pesticide Management Regulatory Agency ap
Nov 30, 2023 09:17 pm ET
Zentek Announces Grant of Stock Options
GUELPH, ON / ACCESSWIRE / November 30, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK);(TSXV:ZEN), an intellectual property technology development and commercialization company announces the granting of 400,000 options total to a director and to an officer of the company exercisable at a price of $1.75 per common share with a term of three years for the officer and five years for the director from the date of the grant. The options will vest one-third on the date of grant, one-third after six months of the date
Nov 29, 2023 10:00 am ET
Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
GUELPH, ON / ACCESSWIRE / November 29, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces successful testing of its COVID-19 High-Binding Affinity (C19HBA) aptamer against the Omicron XBB 1.5 variant (Omicron) by the Miller Lab at McMaster University in the latest pre-clinical study.
Nov 21, 2023 08:20 am ET
Zentek Announces Update on the Albany Graphite Project
GUELPH, ON / ACCESSWIRE / November 21, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company provides an update on its wholly owned subsidiary Albany Graphite Corp. On April 25th, 2023, Zentek announced the intention to transfer its 100% owned, Albany Graphite Deposit, a rare hydrothermal graphite deposit located north of Lake Superior and southwest of James Bay in north-eastern Ontario, to a wholly-owned subsidiary, Albany Grap
Nov 15, 2023 08:15 am ET
Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology
GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved key challenges for manufacturing and these High-Binding Affinity (HBA) aptamers are now produced with a
Oct 17, 2023 09:10 am ET
Zentek Completes Return on Investment Analysis for Canadian Healthcare System
GUELPH, ON / ACCESSWIRE / October 17, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce completion of a study on the potential savings for the Canadian healthcare system from adopting ZenGUARD™-enhanced air filters. This analysis builds on the previously disclosed study announced on September 11, 2023, highlighting the potential return on investment from reduced absente
Oct 10, 2023 10:35 am ET
Zentek Announces Voting Results of Annual and Special Meeting
Guelph, Ontario--(Newsfile Corp. - October 10, 2023) - Zentek Ltd.  (Nasdaq: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders (the "Meeting") held on October 5, 2023. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set out in the Management Information Circular (the "Management Information Circular") dated August 28, 2023. The Management Information Circular is available on SEDAR+ (www.sedarplus.ca).
Oct 10, 2023 09:18 am ET
Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose
GUELPH, ON / ACCESSWIRE / October 10, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce further successful pre-clinical testing of the aptamer-based platform technology by the Dr. Matthew Miller Lab.
Oct 05, 2023 07:15 am ET
Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology
GUELPH, ON / ACCESSWIRE / October 5, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the rapid-detection platform and the recent aptamer-based platform technology developed by Dr. Yingfu Li and his team that
Oct 04, 2023 07:15 am ET
Zentek Provides Corporate Update
GUELPH, ON / ACCESSWIRE / October 4, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to provide a corporate update and recap of its ZenGUARD™ commercialization efforts and other aspects of its operations over the past several months.
Sep 25, 2023 07:15 am ET
Zentek to Showcase ZenGUARD(TM) for HVAC at BUILDEX Alberta 2023
GUELPH, ON / ACCESSWIRE / September 25, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company is pleased to announce its participation in BUILDEX Alberta 2023, Western Canada's largest exhibition and conference connecting the entire building industry. The event is scheduled to take place on October 18 & 19, 2023, at the Calgary TELUS Convention Centre. Zentek will be exhibiting its groundbreaking ZenGUARD™-enhanced HVAC filters.
Sep 21, 2023 07:15 am ET
Zentek Announces Annual General Meeting on Thursday October 5th, 2023, at the Delta Hotel in Guelph, Ontario
GUELPH, ON / ACCESSWIRE / September 21, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce its 2023 Annual General and Special Meeting will be held on Thursday, October 5th at 4:00 pm at the Delta Hotel in Guelph, Ontario. Capacity may be limited, and attendees must register by email at [email protected]. The meeting will be live streamed for those who cannot attend in
Sep 11, 2023 07:15 am ET
Zentek’s ZenGUARD(TM)-Enhanced Filters Demonstrate Robust Return on Investment in ParticleOne Study
GUELPH, ON / ACCESSWIRE / September 11, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce the successful results of a recent study conducted by ParticleOne, an RWDI Ventures company ("RWDI").
Sep 06, 2023 07:15 am ET
Zentek Announces Breakthrough Results in Viral Filtration Efficiency with Dust Loading
GUELPH, ON / ACCESSWIRE / September 6, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce the results of a recent study comparing the Viral Filtration Efficiency ("VFE") of its ZenGUARD™-enhanced MERV 9 filters with an uncoated MERV 9 filter. The testing was performed by the third-party lab LMS Technologies Inc. ("LMS"), which specializes in the testing and certification of filt
Aug 24, 2023 07:15 am ET
Zentek Announces Distribution and Supply Agreement with Henry Schein, Inc.
GUELPH, ON / ACCESSWIRE / August 24, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company has signed a Distribution and Supply Agreement with Henry Schein, Inc. (Henry Schein). This initial agreement will be for a period of three years and is for Canada and the United States. Sales of ZenGUARD™ surgical masks in the United States will commence upon facility establishment registration and issuance of market clearance from the Food and D
Jul 27, 2023 07:15 am ET
Zentek and McMaster University Announce New Aptamer Technology Platform
GUELPH, ON / ACCESSWIRE / July 27, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company and McMaster University (McMaster) are proud to announce that Dr. Yingfu Li and his team at the Li Lab have developed a novel aptamer technology that increases the binding affinity of aptamers by up to 250 times. The increased binding affinity enhances the limits of detection for aptamer-based diagnostics. In addition, the enhanced binding affinity
Jul 26, 2023 07:15 am ET
Albany Graphite Corp. Publishes Mineral Resource Estimate for Globally Unique Igneous Graphite Deposit
GUELPH, ON / ACCESSWIRE / July 26, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce an updated Mineral Resource estimate for the Albany Graphite Project located north of Lake Superior and southwest of James Bay in Northeastern Ontario, which is owned by Zentek's wholly-owned subsidiary Albany Graphite Corp. ("AGC").
Jul 20, 2023 07:15 am ET
Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential
GUELPH, ON / ACCESSWIRE / July 20, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company, is pleased to announce, further to its press release dated May 19, 2022, that its aptamer platform under global exclusive license from McMaster University ("McMaster") has been successfully tested as a potential prophylactic or therapeutic for SARS-CoV-2 in pre-clinical animal models. In repeat trials, the aptamers developed by Dr. Yingf
Jul 13, 2023 07:15 am ET
Zentek Announces Updates to Senior Management Team
GUELPH, ON / ACCESSWIRE / July 13, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company, is pleased to announce updates to its senior management team.
Jun 29, 2023 09:50 pm ET
Zentek Reports on Annual Financial Statements and Audit Committee
GUELPH, ON / ACCESSWIRE / June 29, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK);(TSXV:ZEN), a graphene technology development and commercialization company announces the filing of its audited consolidated financial statements for the financial year and quarter ended March 31, 2023 (the "2023 Annual Financial Statements").
Jun 22, 2023 07:15 am ET
Zentek Provides Update on ZenARMOR(TM) Corrosion Protection Technology
GUELPH, ON / ACCESSWIRE / June 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company has been awarded a research and development contract through Innovative Solutions Canada to test ZenARMOR™ nano-pigment in military grade, chromate-free, corrosion protection aerospace paint systems. The Company previously announced in its February 8th, 2023, ne
Jun 01, 2023 07:15 am ET
Zentek Names Lisa Sim to the Board of Directors
GUELPH, ON / ACCESSWIRE / June 1, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company announces that Ms. Lisa Sim has been appointed to the board of directors of Zentek as an independent director.
May 30, 2023 07:15 am ET
Zentek and Pattern Energy to Collaborate on Icephobic Technology for Wind Turbine Industry
GUELPH, ON / ACCESSWIRE / May 30, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce a collaboration with Pattern Energy Group LP ("Pattern Energy") to optimize, test and validate Zentek's icephobic coating for the wind turbine industry. The partnership is being supported financially by both the Natural Sciences and Engineering Research Council of Canada ("NSERC")
May 24, 2023 07:15 am ET
Zentek Announces Normal Course Issuer Bid
GUELPH, ON / ACCESSWIRE / May 24, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, subject to regulatory approval, it will conduct a normal course issuer bid (the "Bid"). The Bid will be for up to 4,979,349 common shares of the Company over a period of one year (the "Bid Period"), being approximately 5% of Company's issued and outstanding common shares of the Company's issued and outstanding common shares, with up to 1,991,739 commo
May 23, 2023 07:15 am ET
Zentek Announces Transfer of the Albany Graphite Project to Subsidiary
GUELPH, ON / ACCESSWIRE / May 23, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce that further to its press release dated April 24, 2023, the Company has completed the transfer of the Albany Graphite Project (as defined below) to its wholly-owned subsidiary, Albany Graphite Corp. ("Albany") pursuant to a Property Purchase Agreement dated April 24, 2023 (the "Agreement
May 18, 2023 07:15 am ET
Zentek Receives ISO 13485:2016 Certification
GUELPH, ON / ACCESSWIRE / May 18, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company has been granted ISO 13485:2016 Quality Management System (QMS) certification standard by British Standards Institution (BSI). The company has also received Medical Device Single Audit Program (MDSAP) certificate # 777967. These certifications validate Zentek's robust QMS that can handle all regulated products and demonstrate safety, reliability, and qualit
May 04, 2023 07:30 am ET
Zentek Provides Update on Icephobic Technology for Drones
GUELPH, ON / ACCESSWIRE / May 4, 2023 / Further to its press release dated September 19, 2022, Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company, reports successful drone testing, where thrust was maintained under calibrated icing conditions of freezing drizzle and freezing rain in an outdoor, real-world environment. The drone with Zentek's icephobic coating applied to the propeller blades hovered under the outdoor icing rig and, on all tests co
May 03, 2023 07:30 am ET
Zentek Provides Review of Albany Graphite
GUELPH, ON / ACCESSWIRE / May 3, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ ZTEK)(TSXV: ZEN), a graphene technology development and commercialization company, further to its press release dated April 25, 2023 announcing the intention to transfer its Albany Graphite Project located north of Lake Superior and southwest of James Bay in Ontario to its currently wholly-owned subsidiary Albany Graphite Corp., provides a review of some of the past testing conducted on the material produced from the Albany Graphite Proj
Apr 25, 2023 07:30 am ET
Zentek Announces Agreement to Transfer Albany Graphite Project to Subsidiary and Intention of Albany Graphite Corp. to Complete a Private Placement Financing
GUELPH, ON / ACCESSWIRE / April 25, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce the execution of a property purchase agreement (the "Agreement") with its recently incorporated and currently wholly-owned subsidiary Albany Graphite Corp. ("Albany") to transfer the Albany Graphite Project, and the intention of Albany to complete a non-brokered private placement
Apr 14, 2023 08:40 pm ET
Zentek Announces Grant of Stock Options
GUELPH, ON / ACCESSWIRE / April 14, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company, announces the granting of 600,000 options to directors, officers and employees of the company exercisable at a price of $2.12 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of grant, one-third after six months of the date of grant and one-third after 12 months of the date of gr
Apr 05, 2023 07:30 am ET
Zentek Files Patent Applications for ZenGUARD(TM) in Multiple New Jurisdictions
GUELPH, ON / ACCESSWIRE / April 5, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company, has filed patent applications for ZenGUARD™ in 47 countries.
Mar 30, 2023 07:30 am ET
Zentek Engages Arka BRENStech Pvt Ltd to Develop Opportunities in India
GUELPH, ON / ACCESSWIRE / March 30, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV: ZEN), an intellectual property development and commercialization company, has signed an agreement (the "Agreement") with Arka BRENStech Pvt Ltd ("BRENStech"), a company incorporated under the laws of the Republic of India (India), pursuant to which BRENStech will act as a local partner to Zentek as it seeks to develop business opportunities in India.
Mar 22, 2023 07:30 am ET
Zentek Announces New Antimicrobial Testing Results
GUELPH, ON / ACCESSWIRE / March 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK); (TSXV:ZEN), an intellectual property development and commercialization company, announces that SGS Standard Technical Services Co. ("SGS") recently conducted tests to determine the extent of the antimicrobial properties and the time required to achieve deactivation of bacteria and virus on ZenGUARD™-coated mask material.
Mar 17, 2023 07:30 am ET
Zentek To Participate In The Industrial Tech Virtual Conference Presented By Maxim Group LLC and Hosted by M-Vest
GUELPH, ON / ACCESSWIRE / March 17, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, announces its Chief Executive Officer, Greg Fenton, will present at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21, 2023. Mr. Fenton will participate in a virtual fireside chat at 2 p.m. ET.
Mar 03, 2023 04:01 pm ET
Zentek Clarifies Certain Disclosure
GUELPH, ON / ACCESSWIRE / March 3, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that, pursuant to a review by the Ontario Securities Commission (the "OSC") of the Company's continuous disclosure, at the OSC's request, the Company has removed from its website reference to the material resource estimate for the Albany graphite deposit (the "Albany Graphite Deposit") because the technical report entitled "Technical Report on the Pre
Feb 15, 2023 07:30 am ET
Zentek and 1329307 BC Ltd. Sign Letter of Intent to Spin Out Albany Graphite Deposit
GUELPH, ON / ACCESSWIRE / February 15, 2023 / Zentek Ltd. ("Zentek") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, and 1329307 BC Ltd. are pleased to announce that they have signed a non-binding letter of intent dated February 13, 2023 (the "LOI"), pursuant to which the parties have agreed to negotiate a transaction (the "Transaction") involving the transfer of Zentek's Albany Graphite Deposit in northern Ontario to an entity ("SpinCo") to be listed on a recognized Canadian
Feb 08, 2023 07:30 am ET
Zentek Introduces a Novel Corrosion Protection Technology: ZenARMOR(TM)
GUELPH, ON / ACCESSWIRE / February 8, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has developed ZenARMOR™, a novel corrosion protection technology based on functionalized Graphene Oxide (GO) that offers superior performance, self-healing properties and a potential environmental advantage. Corrosion is a costly issue that significantly impacts naval and marine infrastructure, bridges, buildings, pipelines, and many other ind
Feb 06, 2023 07:30 am ET
Zentek Announces Final Results of HVAC Phase 2 Testing
GUELPH, ON / ACCESSWIRE / February 6, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce, further to its press releases dated April 11 2022 and December 15, 2022, that it has received the final report for Phase 2 testing of ZenGUARD™ for use in Heating, Ventilation and Air Conditioning ("HVAC") filtration from the National Research Council of Canada ("NRC"). ZenGUARD™-treated MERV
Jan 19, 2023 08:00 am ET
Zentek Signs Distribution Agreement with Southmedic Inc.
GUELPH, ON / ACCESSWIRE / January 19, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Distribution Agreement with Southmedic Inc. ("Southmedic") for the distribution of Zentek's patented ZenGUARD™ surgical masks. Under the agreement, Southmedic will be the distributor of ZenGUARD™-enhanced surgical masks to the Canadian hospital, general practitioner, private surgery, long-term care and nursing home
Jan 12, 2023 08:00 am ET
Zentek Announces Appointment of New Director of Investor Relations
GUELPH, ON / ACCESSWIRE / January 12, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations.
Dec 15, 2022 08:00 am ET
Zentek Announces Successful Phase 2 Results of HVAC Testing
GUELPH, ON / ACCESSWIRE / December 15, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, reports, further to its press release of April 11, 2022, the successful completion of Phase 2 HVAC filter testing by the National Research Council of Canada ("NRC").
Dec 07, 2022 08:00 am ET
Zentek's ZenGUARD(TM) Patent Application Granted by the Canadian Intellectual Property Office
GUELPH, ON / ACCESSWIRE / December 7, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on December 6, 2022, it was granted Patent Number 3,152,759 for its ZenGUARD™ technology, "graphene-silver composites and uses for same as an antimicrobial composition."
Nov 04, 2022 07:20 pm ET
Zentek Files Amended and Restated Audited Financial Statements
GUELPH, ON / ACCESSWIRE / November 4, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated audited financial statements (the "Amended and Restated Financials") for the financial year ended March 31, 2022, which amend and restate the previously filed audited financial statements for the financial year ended March 31, 2022 (the "Financial Statements"). Part 3.2 of Companion Policy 51-102CP Continuous Di
Oct 28, 2022 08:00 am ET
Zentek Provides Update on Battery Technology Development
GUELPH, ON / ACCESSWIRE / October 28, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the commencement of a 4-year, $1.6M research project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T") and Ford Powertrain Engineering Research and Development Centre ("PERDC"). Funding for the project includes $1.2M from the Mitacs Acce
Oct 19, 2022 08:00 am ET
Zentek to Present ZenGUARD(TM) Technology at the Global Summit on Regulatory Science in Singapore
GUELPH, ON / ACCESSWIRE / October 19, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property ("IP") development and commercialization company, is pleased to announce that it was chosen to present the Company's ZenGUARD™ technology at the 12th Annual Global Summit on Regulatory Science on October 19-21, 2022, in the Innovative Nanotechnology Advancement in the Drug and Medical Device track. The theme of this year's summit, "Advances in Nanotechno
Oct 05, 2022 08:00 am ET
Zentek Announces Voting Results of Annual and Special Meeting
GUELPH, ON / ACCESSWIRE / October 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders (the "Meeting") held on September 29, 2022. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set out in the Management Information Circular (the &
Sep 27, 2022 08:00 am ET
Zentek's ZenGUARD(TM) Patent Application Allowed by the Canadian Patent Office
GUELPH, ON / ACCESSWIRE / September 27, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK); (TSXV:ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on September 16, 2022, it's Canadian patent application directed to its ZenGUARD™ technology, for use on personal protective equipment ("PPE"), and heating, ventilation, and air conditioning ("HVAC"), has been allowed by the Canadian Intellectual Propert
Sep 20, 2022 08:00 am ET
Zentek To Present at Sidoti Small-Cap Virtual Conference
GUELPH, ON / ACCESSWIRE / September 20, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that Greg Fenton, CEO, will hold investor meetings and present at this year's Sidoti Small-Cap Virtual Investor Conference, which will be held September 21-22, 2022.
Sep 19, 2022 08:00 am ET
Zentek Provides Update on Icephobic Coating Technology
GUELPH, ON / ACCESSWIRE / September 19, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has successfully completed sand erosion testing at the National Research Council ("NRC") in Ottawa and rain erosion testing at the Anti-icing Materials International Laboratory ("AMIL") in Quebec on Zentek's patent-pending Icephobic Coatings. These results, when taken with the strong performan
Sep 15, 2022 08:00 am ET
Zentek Provides Update on HVAC Testing
GUELPH, ON / ACCESSWIRE / September 15, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada ("ISC") Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne test organisms without modifica
Sep 08, 2022 08:00 am ET
Zentek Announces Annual General Meeting on Thursday September 29th, 2022, at the Delta Hotel in Guelph, Ontario
GUELPH, ON / ACCESSWIRE / September 8, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce its 2022 Annual General and Special Meeting will be held on Thursday, September 29th at 4:00 pm at the Delta Hotel in Guelph, Ontario. Capacity may be limited, and attendees must register by email at [email protected]. The meeting will be live streamed for those who cannot attend in person,
Sep 07, 2022 08:25 am ET
Zentek Announces Manufacturing and Supply Agreement with Viva Healthcare Packaging (Canada) Ltd. to Manufacture and Sell ZenGUARD(TM)- Enhanced Surgical Masks
GUELPH, ON / ACCESSWIRE / September 7, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, announces it has entered into a Manufacturing and Supply Agreement with Viva Healthcare Packaging (Canada) Ltd. ("VMedCare") to manufacture and sell surgical masks enhanced with Zentek's proprietary ZenGUARD™ antimicrobial coating. During the pandemic, VMedCare quickly became one of the leaders in surgical mask man
Aug 05, 2022 08:30 pm ET
Zentek Provides Update on Commercial Partnerships
GUELPH, ON / ACCESSWIRE / August 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating.
Jul 18, 2022 08:00 am ET
Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent
GUELPH, ON / ACCESSWIRE / July 18, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions."We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek. "This is another demonstration of how we are further commercializing our unique Z
Jul 05, 2022 08:00 am ET
Zentek Announces Appointment of New Board Director
GUELPH, ON / ACCESSWIRE / July 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors.
Jun 06, 2022 08:00 am ET
Zentek Provides Update on ZenGUARD(TM) Patent Status
GUELPH, ON /ACCESSWIRE / June 6, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that on March 28, 2022, the Canadian national phase was initiated for its patent application directed to its ZenGUARD™ technology. Zentek's patent strategy typically begins by filing one or more provisional patent applications with the United States Patent and Trademark Office. This allows the Company to establish the earlie
May 26, 2022 08:00 am ET
Zentek Announces Opening of its Industrial Scale ZenGUARD(TM) Production Facility in Guelph, Ontario
GUELPH, ON / ACCESSWIRE / May 26, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to announce the grand opening of its industrial scale ZenGUARD™ antimicrobial production facility in Guelph, Ontario on Friday June 17th, 2022, at 2:00 pm. This facility is one of the largest nanomaterials-based manufacturing facilities in the world.
May 19, 2022 08:00 am ET
Zentek's Rapid Diagnostic Platform Receives Two NSERC Grants Towards Commercialization
GUELPH, ON / ACCESSWIRE / May 19, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that McMaster University ("McMaster") has received two Natural Sciences and Engineering Research Council ("NSERC") Grants related to the aptamer-based rapid detection technology exclusively licensed by Zentek pursuant to its licence agreement dated April 11, 2021 with McMaster
May 16, 2022 08:00 am ET
Zentek Announces Organizational Update and Appointment of Chief Financial Officer
GUELPH, ON / ACCESSWIRE / May 16, 2022 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that Wendy Ford has been appointed as the new Chief Financial Officer (" CFO ") for the organization. Ms. Ford has more than three decades of experience in finance and accounting leadership roles for both private and publicly traded companies. Brian Bosse will transition from his role as CFO to focus his efforts
May 13, 2022 09:20 am ET
Zentek Announces Sales and Distribution of ZenGUARD(TM) Masks through Mark’s in Canada
GUELPH, ON / ACCESSWIRE / May 13, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that Mark's, a member of the Canadian Tire Family of Companies, has placed an initial order for ZenGUARD™ coated-masks to be sold at select stores across Canada, and online.
Apr 18, 2022 08:00 am ET
Zentek Engages The Benchmark Company to Explore and Advise on Strategic Options for Albany Deposit
GUELPH, ON / ACCESSWIRE / April 18, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK; TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces it has engaged The Benchmark Company, LLC ("Benchmark") to act as strategic financial advisor with respect to potential transactions relating to its Albany Graphite Deposit in Northern Ontario.
Apr 12, 2022 08:00 am ET
Zentek Signs Supply Agreement with EkoMed Global Inc. to Manufacture ZenGUARD-enhanced PPE
GUELPH, ON / ACCESSWIRE / April 12, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces it has signed a definitive supply agreement with EkoMed Global Inc. ("EkoMed"), a globally integrated manufacturer and distributor of personal protective equipment ("PPE"), pursuant to which (i) Zentek will sell quantities of its proprietary ZenGUARD™ coating to EkoMed for
Apr 11, 2022 08:00 am ET
Zentek Announces Start of Phase Two Testing of ZenGUARD(TM) - Coated Filters Under ISC Testing Stream Contract
GUELPH, ON / ACCESSWIRE / April 11, 2022 / further to its press release dated November 30, 2021, Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces that after successful completion of Phase 1 testing of its ZenGUARD™-coated HVAC filters, it will proceed to Phase 2 testing within its Innovation Solutions Canada ("ISC") Testing Stream contract.
Mar 30, 2022 08:00 am ET
Zentek Announces Partnership with FTI Consulting to Support U.S. Expansion Strategy
GUELPH, ON / ACCESSWIRE / March 30, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces its partnership with FTI Consulting (Government Affairs), LLC ("FTI"), a Washington, D.C. based global advisory firm, to support its efforts to bring ZenGUARD™ and its other technologies to the U.S. "Zentek's partnership with FTI will help the Company expand its presence in the U.S. market in a numbe
Mar 28, 2022 08:00 am ET
Zentek Announces Filing of Provisional Patent for Fire-Retardant Additive
GUELPH, ON / ACCESSWIRE / March 28, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK; TSX-V:ZEN), a Canadian intellectual property development and commercialization company, has filed a provisional patent with the United States Patent and Trademark Office for an innovative Graphene Oxide-Metal-Organic Framework (GO-MOF) compound for use in fire retardant products. The compound contains only components that are generally considered environmentally friendly, and no solvents or toxic chemicals, as environmental, soc
Mar 24, 2022 11:50 am ET
Zentek's ZenGUARD(TM) Patent Application Publishes
GUELPH, ON / ACCESSWIRE / March 24, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, is pleased to announce that its international patent application for its ZenGUARD™ technology has been published by the World Intellectual Property Office.
Mar 23, 2022 10:59 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, March 23, 2022 /CNW/ - Trading resumes in:
Mar 23, 2022 10:51 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, March 23, 2022 /CNW/ - The following issues have been halted by IIROC:
Mar 21, 2022 08:00 am ET
Zentek To Begin Trading Common Stock on NASDAQ March 22, 2022
GUELPH, ON / ACCESSWIRE / March 21, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK; TSX-V:ZEN; and OTC PINK:ZENYF), a Canadian intellectual property development and commercialization company, is pleased to announce that its SEC Form 40-F registration statement will be effective at the close of business today, and that its common stock has been approved and will commence trading on the Nasdaq Capital Market ("Nasdaq") under the symbol "ZTEK" on Tuesday, March 22, 2022.
Mar 14, 2022 08:00 am ET
Zentek Reports on Icephobic Testing
GUELPH, ON / ACCESSWIRE / March 14, 2022 / Zentek Ltd. ("Zentek" or the "Company") (TSX-V:ZEN and OTC:ZENYF), a Canadian IP (Intellectual Property) development and commercialization company, is pleased to report excellent results in three rounds of testing of its icephobic coating, including laboratory tests, real-world flights and applications related to drone operations in adverse weather. To support this effort, Zentek has undertaken UV weathering testing to assess the durability of these coatings with the view to demons
Mar 10, 2022 08:00 am ET
Zentek Engages Vimta Labs for Clinical Research
GUELPH, ON / ACCESSWIRE / March 10, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP (Intellectual Property) development and commercialization company focused on next-gen healthcare solutions, today announces that it has retained Vimta Labs Limited ("Vimta"), a leading clinical research organization in India, to begin studies of ZEN's ZenGUARD™ active ingredient as a potential treatment of infectious skin disease.
Mar 09, 2022 08:42 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, March 9, 2022 /CNW/ - The following issues have been halted by IIROC:
Mar 09, 2022 08:00 am ET
Clarification on Intellectual Property Matters
GUELPH, ON / ACCESSWIRE / March 9, 2022 / Zentek Ltd. ("ZEN" or the "Company")(TSX-V:ZEN and OTC PINK:ZENYF), wants to clarify that the technology utilized in its ZenGUARD™ antimicrobial coating was developed exclusively by ZEN at its facility in Guelph, Ontario during the summer of 2020. Zentek's ZenGUARD™ technology does not use any of the technology related to the claim made in the patent applications of Graphene Composites Ltd. ("GC").
Mar 09, 2022 07:28 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, March 9, 2022 /CNW/ - Trading resumes in:
Mar 08, 2022 05:45 pm ET
Zentek Provides Update on Rumours
GUELPH, ON / ACCESSWIRE / March 8, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions has become aware of certain rumours and allegations being circulated, and categorically refutes the egregious allegation regarding the theft of intellectual property from Graphene Composites Ltd.
Mar 08, 2022 11:50 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, March 8, 2022 /CNW/ - The following issues have been halted by IIROC:
Mar 08, 2022 08:00 am ET
Zentek Welcomes Ravi Kaza to Advisory Board
GUELPH, ON / ACCESSWIRE / March 8, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, today announces the addition of Mr. Ravi Kaza to its Advisory Board.
Mar 07, 2022 08:00 am ET
Zentek Receives Approval for Nasdaq Listing
GUELPH, ON / ACCESSWIRE / March 7, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, today announces that it has received approval to have its common stock listed on the Nasdaq Capital Market ("Nasdaq") under the symbol ZTEK. Zentek's common stock will continue to trade on the TSX Venture Exchange (TSX-V) under the symbol ZEN. The Company is evaluating market conditions and other consideratio
Feb 28, 2022 08:30 am ET
Zentek Provides Corporate Update
GUELPH, ON / ACCESSWIRE / February 28, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces the following corporate updates:
Feb 18, 2022 08:00 am ET
Zentek Announces Development of Graphene-Wrapped Silicon Anodes
GUELPH, ON / ACCESSWIRE / February 18, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, announces today that it has filed a provisional patent with the United States Patent and Trademark Office on a novel Graphene-Wrapped Silicon Anode material developed by Prof. Michael Pope, an Associate Professor in the Department of Chemical Engineering at the University of Waterloo along with Dr. Marianna Uceda and D
Jan 17, 2022 09:15 am ET
Zentek to Present at the Sidoti & Company Virtual Small Cap Conference
GUELPH, ON / ACCESSWIRE / January 17, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN) and (OTC:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces that Chief Executive Officer Greg Fenton will present at the Sidoti & Company Virtual Small Cap Conference being held from January 19 - 20, 2022.
Jan 14, 2022 07:30 pm ET
Zentek Announces Grant of Stock Options
GUELPH, ON / ACCESSWIRE / January 14, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces the granting of 1,300,000 options to directors, officers and employees of the company exercisable at a price of $4.25 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of grant, one-third after six months of the date of grant and one-third afte
Jan 13, 2022 09:25 am ET
Zentek Announces Binding Letter of Intent with GMAF Circular Medico for ZENGuard(TM)-Enhanced Circular PPE(TM)
GUELPH, ON / ACCESSWIRE / January 13, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to announce that it has entered into a binding letter of intent (the "LOI") with GMAF Circular Medico ApS ("GMAF") to produce and sell ZENGuard™-enhanced GMAF trademarked recyclable surgical masks ("Circular PPE
Jan 11, 2022 08:50 am ET
Zentek Announces First Direct Orders Under Its Medical Device Establishment License
GUELPH, ON / ACCESSWIRE / January 11, 2022 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to announce that it has commenced receiving direct retail orders for ZENGuard™-enhanced surgical masks under its Medical Device Establishment License ("MDEL") recently issued by Health Canada, further to the Company's press release dated November 29, 2021.
Jan 04, 2022 09:30 am ET
Zentek Announces Closing of C$23 Million Bought Deal Public Offering and C$10 Million Non-Brokered Private Placement, for Aggregate Proceeds of C$33 Million
Guelph, Ontario--(Newsfile Corp. - January 4, 2022) - Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company") a Canadian, IP development and commercialization company focused on next-gen healthcare solutions is pleased to announce, further to its press releases dated November 16, 2021 and December 23, 2021, that it has closed its previously announced bought-deal prospectus offering (the "Prospectus Offering") for gross proceeds of C$23,005,060, which includes the full exercise of the over-allotment option, and its concurrent non-brokered private placement (the "Concurrent Private Placement") for aggregate gross proceeds of C$10,009,022.
Dec 23, 2021 10:23 pm ET
Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing
Guelph, Ontario--(Newsfile Corp. - December 23, 2021) - Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company"), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, announces, in connection with a review by Staff of the Ontario Securities Commission (the "OSC"), the filing of amended and restated unaudited condensed consolidated interim financial statements (the "Q2 2021 FS") and management's discussion and analysis thereof ("Q2 2021 MDA", together with the Q2 2021 FS, the "Amended Statements"), and provides updates on its business developments over the past year, including the development of its patent-pending anti-microbial ZENGuard™ compound, its licensing status with Health Canada, its commercial revenue-generating agreement with Trebor Rx Corp. ("Trebor"), the development of the Company's planned industrial scale production plant, and certain of its other previously disclosed initiatives.
Nov 30, 2021 08:00 am ET
Zentek Awarded ISC Testing Stream Contract to Test ZENGuard(TM)-Coated HVAC Filters
GUELPH, ON / ACCESSWIRE / November 30, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has been awarded an R&D test contract through the Innovation Solutions Canada (ISC) Testing Stream Call for Proposals to test ZENGuard™-coated HVAC filters with interest from 3 different units within the National Research Council of
Nov 29, 2021 08:00 am ET
Zentek Receives Medical Device Establishment License from Health Canada
GUELPH, ON / ACCESSWIRE / November 29, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has been issued a Medical Device Establishment License ("MDEL") from Health Canada (license number 18823) for the manufacture and distribution of class one medical devices. This will allow the Company to begin working with other manufacturers and distributors - in addition to Trebor Rx Corp
Nov 24, 2021 08:00 am ET
Zentek Ltd. Announces Filing of Preliminary Prospectus in Connection with $30,010,172 Offering
GUELPH, ON / ACCESSWIRE / November 24, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF), is pleased to announce that, further to the news release of November 16, 2021, the Company has filed a preliminary prospectus dated November 22, 2021 in order to qualify the distribution of 5,129,944 common shares of the Company (the "Common Shares") at a purchase price of $5.85 per Common Share (the "Offering Price") for aggregate gross proceeds of $30,010,172 (
Nov 17, 2021 08:24 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, Nov. 17, 2021 /CNW/ - Trading resumes in:
Nov 16, 2021 04:52 pm ET
Zentek Announces C$20 Million Bought Deal Public Offering and C$12.5 Million Non-Brokered Private Placement
Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF) a Canadian, IP development and commercialization company focused on next-gen healthcare solutions announces that it has entered into an agreement with Eight Capital as lead underwriter...
Nov 16, 2021 02:51 pm ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, Nov. 16, 2021 /CNW/ - The following issues have been halted by IIROC:
Nov 11, 2021 08:05 am ET
Zentek Provides Corporate Update
GUELPH, ON / ACCESSWIRE / November 11, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces the following corporate updates:
Nov 09, 2021 07:55 am ET
Zentek Provides Update on Rapid Detection Technology
GUELPH, ON / ACCESSWIRE / November 9, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to provide an update on its leading-edge rapid detection platform:
Nov 04, 2021 08:00 am ET
Zentek Wins ISC Challenge to Develop a Portable Detection Device for SARS-CoV-2 in Wastewater
GUELPH, ON / ACCESSWIRE / November 4, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN)(OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, announces it has been selected as one of three technologies for phase 1 of the Innovation Solutions Canada (ISC) challenge to develop a portable detection device for SARS-CoV-2 in wastewater. ZEN has received a $148,000 award from ISC to develop its first prototype.
Nov 02, 2021 08:00 am ET
Zentek Develops New Carbon-Based Nanotechnology-Enhanced Icephobic Coating to Reduce Ice Accretion
Company anticipates applications for aircraft, wind turbines, ocean vessels, and building structures to increase safety and efficiency outcomes in ice-forming weather conditions
Oct 28, 2021 08:00 am ET
Zentek Continues to Build Strong Leadership with Additions to Management Team and Advisory Board
GUELPH, ON / ACCESSWIRE / October 28, 2021 / Zentek Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has added to its management team and Advisory Board to help drive forward the company's execution on its business plans.
Oct 27, 2021 08:00 am ET
ZEN Graphene Solutions Announces Name Change to Zentek Ltd
GUELPH, ON / ACCESSWIRE / October 27, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, intellectual property development company focused on next-gen healthcare solutions, is pleased to announce that it has filed articles of amendment to change its name to "Zentek Ltd." (the "Name Change"). The Name Change was approved by shareholders of the Company at its annual and special meeting held on September 27, 2021. The Common Shares are ex
Oct 21, 2021 09:35 am ET
ZEN Graphene Solutions to Present at the Benzinga Global Small Cap Conference
GUELPH, ON / ACCESSWIRE / October 21, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces today that Chief Executive Officer, Greg Fenton will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 - 28, 2021.
Oct 14, 2021 04:00 pm ET
ZEN Graphene Solutions Announces Completion of Change of Classification on the TSX Venture Exchange to Industrial, Technology, Life Sciences Issuer
GUELPH, ON / ACCESSWIRE / October 14, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that, further to its press release dated August 26, 2021, it has received final approval from the TSX Venture Exchange ("TSXV") to change its classification on the TSXV from a "mining issuer" to an "industrial, technology, or life sciences issuer." The change of classificat
Oct 13, 2021 08:00 am ET
ZEN Graphene Solutions Announces Submission of Nasdaq Listing Application
GUELPH, ON / ACCESSWIRE / October 13, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has submitted an application to list its common stock on The Nasdaq Capital Market® ("Nasdaq") and that it has retained Donohoe Advisory Associates LLC to assist with the listing process. The listing of the Company's common shares on the Nasdaq remains subject to the approval by Na
Oct 06, 2021 08:00 am ET
ZEN Graphene Solutions Announces Filing of Patent Applications Under the Patent Cooperation Treaty
GUELPH, ON / ACCESSWIRE / October 6, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company")(TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has filed a full international patent application for its ZENGuard™ compound under the Patent Cooperation Treaty (PCT). The company elected to file an international patent due to the global opportunities for its technology.
Oct 04, 2021 07:20 pm ET
ZEN Graphene Solutions Announces Notice of Accelerated Expiry of Warrants
GUELPH, ON / ACCESSWIRE / October 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF) gives notice of accelerated expiry to the holders of 760,848 common share purchase warrants ("2021 Warrants") of the Company, which were issued pursuant to a private placement completed on April 8, 2021 and 1,419,753 warrants (the "2020 Warrants") of the Company which were issued pursuant to a private placement completed on July 6, 2020.
Oct 04, 2021 08:00 am ET
ZEN Graphene Solutions Highlights Results of Annual Shareholder Meeting
Company receives shareholder support to transition toward its nanotechnology and health sciences focus
Sep 27, 2021 04:00 pm ET
ZEN Graphene Solutions Finalizes Definitive Commercial Agreement with Trebor Rx
GUELPH, ON / ACCESSWIRE / September 27, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has signed a definitive commercial agreement with Trebor Rx (Trebor) for the manufacturing of ZENGuard™-enhanced personal protective equipment. The agreement includes surgical masks, filters for Trebor's patent pending Pro+ mask, nitrile gloves and other potential products.
Sep 27, 2021 08:00 am ET
ZEN Graphene Solutions Announces ZENGuard Viral and Bacterial Filtration Efficiency Test Results
GUELPH, ON / ACCESSWIRE / September 27, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces test results demonstrating significantly enhanced bacterial filtration efficiency (BFE) and viral filtration efficiency (VFE) of ZENGuard™-enhanced surgical masks. The ZENGuard™ coated masks removed 98.9% more bacteria and 97.8% more virus particles compared to a typi
Sep 23, 2021 08:00 am ET
ZEN Graphene Solutions Announces Initial Revenue Generation from Delivery of First ZENGuard Shipment
GUELPH, ON / ACCESSWIRE / September 23, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that it has delivered and generated revenue from its first shipment of ZENGuardTM antimicrobial coating to Trebor Rx (Trebor).
Sep 22, 2021 10:45 am ET
ZEN Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuard Mask
GUELPH, ON / ACCESSWIRE / September 22, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces Health Canada approval of ZENGuard™ disposable face mask with biocidal coating and is rated at an ASTM Level 3. The review process included extensive examination of data related to shedding, inhalation safety, skin irritation, pathogen deactivation, bacterial filtration efficiency and
Sep 20, 2021 08:00 am ET
ZEN Graphene Solutions to Present at the Sidoti Fall Virtual Investor Conference
GUELPH, ON / ACCESSWIRE / September 20, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that Chief Executive Officer, Greg Fenton will present at the Sidoti Fall Virtual Investor Conference, which is being held September 22 - 23, 2021.
Sep 14, 2021 08:00 am ET
ZEN Graphene Solutions Ltd. Announces COVID-19 Protocols for Annual General Meeting of Shareholders
THUNDER BAY, ON / ACCESSWIRE / September 14, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, would like to notify shareholders that have registered and received confirmations that they are welcome to attend the Company's Annual General Meeting (AGM) of shareholders on September 27, 2021. Due to COVID-19 and its threat to the community, we are required to follow certain procedures at our upcoming AGM that are aligned with the requirements laid
Sep 03, 2021 05:50 pm ET
ZEN Graphene Solutions Announces Grant of Options
GUELPH, ON / ACCESSWIRE / September 3, 2021 / ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) and (OTC PINK:ZENYF), ) announces stock option grants for two employees. These options are exercisable for an aggregate of 100,000 common shares at an exercise price of $3.69 per common share for a period of three years from the date of the grant which will vest one-third on the date of grant, one-third after six months of the date of grant and one-third after 12 months of the date of grant.
Aug 26, 2021 04:00 pm ET
ZEN Graphene Solutions Announces Shareholder Meeting Monday September 27th, 2021, at the Delta Hotel in Guelph, Ontario
THUNDER BAY, ON / ACCESSWIRE / August 26, 2021 / ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce the 2021 Shareholder Meeting will be held on Monday, September 27th at 4pm at the Delta Hotel in Guelph, Ontario. Due to COVID-19, capacity will be limited to the first 50 shareholders who register by email at [email protected]
Aug 25, 2021 05:15 pm ET
ZEN Graphene Solutions Announces Proposed Change of Classification on the TSX Venture Exchange to Industrial, Technology, Life Sciences Issuer
GUELPH, ON / ACCESSWIRE / August 25, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that it has made an application to change its classification on the TSX Venture Exchange ("TSXV") from a mining issuer to an industrial, technology, life sciences issuer.
Aug 11, 2021 07:00 am ET
ZEN Graphene Solutions: Invitation to the Q3 Virtual Investor Summit
Guelph, Ontario--(Newsfile Corp. - August 11, 2021) - ZEN Graphene Solutions (TSXV: ZEN) today announced that Dr. Francis Dube, Executive Chair will be attending the Q3 Virtual Investor Summit.
Jun 30, 2021 08:00 am ET
ZEN Graphene Solutions Announces Addition of Dr. Ken Reed to Advisory Board
GUELPH, ON / ACCESSWIRE / June 30, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that Dr. Kenneth Reed, Medical Director at DermASAP, will join the ZEN Advisory Board effective immediately. Dr. Reed, a Harvard Medical School trained dermatologist, has 38 years of clinical experience in the state of Massachusetts. Dr. Reed will devote significant time and attention to advancing ZEN's topical therapeuti
Jun 17, 2021 10:45 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, June 17, 2021 /CNW/ - Trading resumes in:
Jun 17, 2021 10:23 am ET
ZEN Graphene Solutions Announces Exclusive Worldwide Rights to Commercialize Rapid, Saliva-Based COVID-19 Antigen Testing Technology
GUELPH, ON / ACCESSWIRE / June 17, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it has signed an exclusive agreement with McMaster University to be the global commercializing partner for a newly developed aptamer-based, SARS-CoV-2 rapid detection technology, developed by a team of researchers under the guidance of Drs. Yingfu Li, John Brennan and Leyla Soleymani, who are recognized as global leaders
Jun 17, 2021 09:21 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, June 17, 2021 /CNW/ - The following issues have been halted by IIROC:
Jun 16, 2021 08:40 am ET
ZEN Graphene Solutions and Trebor Rx Provides Update
GUELPH, ON / ACCESSWIRE / June 16, 2021 / ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to provide an update on the Health Canada review process for the ZEN Guard TM -enhanced, ASTM level 3 surgical mask. ZEN has been advised by Trebor that it received a response letter from Health Canada indicating that more information was required following their first full revi
Jun 04, 2021 09:50 am ET
ZEN Graphene Solutions and Trebor RX Announce Successful Inhalation Safety Testing of ZENGuard(TM)-Enhanced Surgical Masks and Final Submission to Health Canada
GUELPH, ON / ACCESSWIRE / June 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to announce successful inhalation safety testing results of ZENGuardTM-enhanced surgical masks and submission of these results to Health Canada. Testing was completed by NanoSafe Inc. (NanoSafe) in Blacksburg, Virginia confirmed that no ZENGuardTM graphene material was released from the surgical masks wit
Jun 01, 2021 11:30 am ET
ZEN Graphene Solutions Develops Fuel Additive
GUELPH, ON / ACCESSWIRE / June 1, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it has developed a stable diesel fuel additive, which increased the performance of diesel fuel by up to 10% in initial testing. These tremendous early results can be improved further through additional optimization work. ZEN has filed a provisional patent for this graphene-based fuel additive technology.
May 03, 2021 08:30 am ET
ZEN Graphene Solutions Announces Ingestion Good Laboratory Practice Study for its Graphene-Based Compound
GUELPH, ON / ACCESSWIRE / May 3, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it will begin an ingestion Good Laboratory Practice (GLP) compliant safety study of its patent-pending, graphene-based compound following successful testing against Clostridium Difficile (C. Difficile) at the University of Manitoba under the supervision of Dr. George Zhanel, Professor, Department of Medical Microbiology and Infectious Disease and Di
Apr 13, 2021 08:00 am ET
ZEN Graphene Solutions Submits Information to Health Canada and Provides Corporate Update
GUELPH, ON / ACCESSWIRE / April 13, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX.V:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to provide an update on the following:
Apr 09, 2021 08:00 am ET
Zen Graphene Solutions Completes Private Placement for Gross Proceeds of $4.3 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Apr 05, 2021 08:00 am ET
ZEN Graphene Solutions Comments on Graphene in Protective Face Masks
GUELPH, ON / ACCESSWIRE / April 5, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is aware of the statements from Health Canada (HC) regarding masks containing graphene and is aligned and supportive of the steps taken to regulate the use of graphene and remove products that are unsafe for the public. ZEN has had comprehensive testing performed on its biocidal coating and demonstrated that it can provide an added level of protection for f
Apr 01, 2021 08:30 am ET
Zen Graphene Solutions Ltd. Announces Final Upsize of Private Placement
THUNDER BAY, ON / ACCESSWIRE / April 1, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX Venture Exchange:ZEN) is pleased to announce, in connection with its previously announced non-brokered private placement (the "Offering"), and previous upsizing, that due to very strong demand the Company has increased the size of the Offering to up to 2,000,000 units (the "Units") at a price of CDN$2.50 per Unit for gross proceeds of up to CDN$5,000,000. The private placement is now closed to new interest as the company finalizes the transacti
Mar 30, 2021 08:45 am ET
ZEN Graphene Solutions Ltd. Announces Second Upsize of Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Mar 26, 2021 09:30 am ET
ZEN Graphene Solutions Ltd. Announces Upsize of Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Mar 25, 2021 08:00 am ET
Zen Graphene Solutions Ltd. Announces Non-Brokered Private Placement of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.
Mar 24, 2021 09:50 am ET
ZEN Graphene Solutions Announces 2021 Biocidal Coating Production Plans
GUELPH, ON / ACCESSWIRE / March 24, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC Pink:ZENYF), a next-gen nanomaterials technology company, is pleased to announce its preliminary biocidal coating production plan to meet the strong demand in the personal protective equipment (PPE) and air filtration markets. ZEN successfully transitioned from bench scale to pilot scale and has begun investing in additional pilot-scale capacity to help meet immediate demands. This intermediate step will significantly increase our current capac
Mar 17, 2021 10:43 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, March 17, 2021 /CNW/ - Trading resumes in:
Mar 17, 2021 10:00 am ET
ZEN Graphene Solutions Announces Successful Testing of Its Graphene Compound Against Antimicrobial-Resistant Bacteria
GUELPH, ON / ACCESSWIRE / March 17, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) and (OTCPINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce successful testing results of its patent-pending graphene-based compound against four gram-positive and nine gram-negative bacteria with antimicrobial-resistance (AMR), including multidrug-resistant variants like methicillin-resistant staphylococcus aureus (MRSA). Testing was completed under the direction of Dr. Tony Mazzulli, MD, FRCPC, FACP, Microbiologist-i
Mar 17, 2021 09:06 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, March 17, 2021 /CNW/ - The following issues have been halted by IIROC:
Mar 04, 2021 01:55 pm ET
ZEN Graphene Solutions and Constance Lake First Nation Sign Implementation Agreement for Albany Project Development
THUNDER BAY, ON / ACCESSWIRE / March 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC Pink:ZENYF) is pleased to announce further steps in collaboration with Constance Lake First Nation (CLFN) led by Chief Rick Allen. Pursuant to the July 13, 2011, Exploration Agreement, the July 19, 2018, Memorandum of Understanding and subsequent September 24, 2018 amendment, both parties have now signed an Implementation Agreement (IA).
Mar 03, 2021 09:45 am ET
ZEN Graphene Solutions and Trebor Rx Corp. Announce Successful Health Canada Testing Requirements of Surgical Masks
GUELPH, ON / ACCESSWIRE / March 3, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC Pink:ZENYF), a next-gen nanomaterials technology company, is pleased to announce it has been advised by Trebor Rx Corp. (Trebor) that their surgical masks with ZEN's biocidal coating have passed Health Canada testing requirements as a level 2 medical device. The coated masks were tested at a Health Canada approved facility in line with American Society for Testing and Materials (ASTM) standards. Trebor intends to begin marketing the ZEN coat
Mar 03, 2021 08:55 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, March 3, 2021 /CNW/ - Trading resumes in:
Mar 03, 2021 07:52 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, March 3, 2021 /CNW/ - The following issues have been halted by IIROC:
Mar 02, 2021 08:00 am ET
ZEN Graphene Solutions Announces Successful Phase 2 Cytotoxicity Testing Results
GUELPH, ON / ACCESSWIRE / March 2, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce successful phase 2 results from cytotoxicity testing of its graphene-based compound. Nucro-Technics recorded no adverse effects after seven days of repeated dosing with concentrations many thousands of times higher than those found to be 99.9% effective against viruses, bacteria, and fungi.
Feb 24, 2021 09:30 am ET
ZEN Graphene Solutions Named to the TSX Venture 50
GUELPH, ON / ACCESSWIRE / February 24, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce that it has been recognized as a Venture 50 company by the TSX Venture Exchange for 2020. The TSX Venture 50 is a ranking of the top performers on the TSX Venture Exchange over the last year based on three equally weighted criteria: market capitalization growth, share price appreciation, and trading volume.
Feb 04, 2021 08:45 am ET
ZEN Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound
GUELPH, ON / ACCESSWIRE / February 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN) and (OTC:ZENYF) is pleased to announce very promising initial phase 2 results of the 7-day repeated dose safety testing from Nucro Technics for potential human pharmaceutical use of its graphene-based compound.
Jan 20, 2021 08:20 am ET
ZEN Graphene Solutions Announces New Team Members to Support Current Opportunities and Future Growth
GUELPH, ON / ACCESSWIRE / January 20, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC PINK:ZENYF) is pleased to announce the addition of the following individuals to its talented and growing team:
Jan 18, 2021 08:44 am ET
ZEN Graphene Solutions and TreborRx Announce Nitrile Glove Agreement and Provide Health Canada Update
Guelph, Ontario--(Newsfile Corp. - January 18, 2021) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce the following related to its proprietary, graphene-based coating that is 99.9% effective against aerobic bacteria (gram-positive and gram-negative), fungi and viruses, including COVID-19:
Jan 13, 2021 09:57 am ET
ZEN Graphene Solutions Provides Update on Graphene-Based Coating and Filtration Flow Rates
Guelph, Ontario--(Newsfile Corp. - January 13, 2021) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce the following related to its proprietary, graphene-based coating that is 99.9% effective against aerobic bacteria (gram-positive and gram-negative), fungal and viral activity, including COVID-19:
Dec 30, 2020 06:15 pm ET
ZEN Graphene Solutions Announces Grant of Stock Options
Guelph, Ontario--(Newsfile Corp. - December 30, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") announces stock option grants for its directors, officers, employees and consultants. These options are exercisable for an aggregate of 1,425,000 common shares at an exercise price of $3.32 per common share for a period of three to five years from the date of the grant. Directors and officers of the company were granted 1,300,000 options which will vest one-third on the date of grant, one-third after six months of the date of grant and one-third after 12 months of the date of grant. The remaining 125,000 options issued to employees and consultants will vest as to one-third on the date of grant, one-third on the first anniversary of the date of grant and one-third on the second anniversary of the date of grant.
Dec 29, 2020 09:32 am ET
ZEN Graphene Solutions Provides Update on Cytotoxicity Testing of Graphene-Based Compound and Effectiveness of Graphene-Based Coating
Guelph, Ontario--(Newsfile Corp. - December 29, 2020) - ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV: ZEN) (OTC: ZENYF) is pleased to announce the following:
Dec 29, 2020 08:57 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, Dec. 29, 2020 /CNW/ - Trading resumes in:
Dec 29, 2020 08:10 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, Dec. 29, 2020 /CNW/ - The following issues have been halted by IIROC:
Dec 22, 2020 01:52 pm ET
ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans
Guelph, Ontario--(Newsfile Corp. - December 22, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Recently received testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including, upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms. Testing was conducted by Dr. Tony Mazzulli, MD, FRCPC, FACP, Microbiologist-in-Chief & Infectious Disease Specialist at Mount Sinai Hospital. Dr. Mazzulli is also a Professor at the Departments of Laboratory Medicine & Pathobiology and Medicine at the University of Toronto.
Dec 22, 2020 01:12 pm ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, Dec. 22, 2020 /CNW/ - Trading resumes in:
Dec 22, 2020 07:26 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, Dec. 22, 2020 /CNW/ - The following issues have been halted by IIROC:
Dec 08, 2020 08:40 am ET
ZEN Graphene Solutions Announces Corporate Reorganization
Guelph, Ontario--(Newsfile Corp. - December 8, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") announces the appointment of Mr. Gregory Fenton, CFA as its new Chief Executive Officer (CEO). Mr. Fenton has been instrumental in crafting the strategic direction of the company since his appointment to the Board of Directors in July 2018 and has the full confidence of the Board to continue his excellent work as CEO of the company. As a Chartered Financial Analyst and seasoned investment professional, his career includes being a partner in three different investment firms, heading the Risk Solutions Group at Scotiabank, and leading the Liability Driven Investment Group at National Bank Financial. His experience spans many disciplines: capital markets, investment management, actuarial, pension, insurance, accounting, tax, and risk management.
Dec 07, 2020 09:57 am ET
ZEN Graphene Solutions Provides Research Update
Guelph, Ontario--(Newsfile Corp. - December 7, 2020) -  ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") in partnership with Professor Mohammad Arjmand is pleased to announce the award of a $780,000 Alliance Grant ($480,000 from the Natural Sciences and Engineering Research Council of Canada (NSERC) and $300,000 from a combination of cash and in kind contributions from ZEN). Alliance Grants are awarded through a competitive peer review process, and this proposal, titled "Synthesis of Graphene Nanomaterials and Development of Their Multifunctional Polymer Nanocomposites", is ZEN's highest single monetary grant award from NSERC to date and supports NSERC's growing interest in nanomaterials.
Nov 30, 2020 08:00 am ET
ZEN Graphene Solutions Ltd. Signs Graphene Oxide Purchase Agreement
Guelph, Ontario--(Newsfile Corp. - November 30, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company") is pleased to announce it has purchased, for immediate delivery, approximately 200 kg of Graphene Oxide (GO), a key ingredient in the manufacturing of ZEN's patent-pending graphene based viricidal coating. Furthermore, the company has negotiated terms to purchase additional GO by the tonne commencing in January 2021. This Purchase Agreement (PA) will permit ZEN to fulfill its obligations under the previously announced binding letter of intent signed with Trebor Rx Corp., and will also provide additional supply capacity for ZEN's viricidal coating in the PPE and HVAC filtration markets.
Nov 12, 2020 08:00 am ET
ZEN Graphene Solutions Signs Lease for Manufacturing Facility in Guelph
Guelph, Ontario--(Newsfile Corp. - November 12, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OCT Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce that it has signed a three year lease with an option for another 3 years on 25,680 square feet of newly built B.1 industrial zoning space in Guelph, Ontario. The new space will become ZEN's manufacturing facility and corporate headquarters. Engineering work plus the purchase of the equipment required to produce ZEN's graphene-based viricidal coating at commercial scale is ongoing. The company expects to begin initial production in Q4 2020 for incorporation into masks, other PPE and for HVAC filters and prefilters.
Nov 09, 2020 01:17 pm ET
ZEN Graphene Solutions and Trebor RX Corp. Sign Binding Letter of Intent
Guelph, Ontario--(Newsfile Corp. - November 9, 2020) -  ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce that it has signed a binding letter of intent (LOI) with Trebor Rx Corp. (Trebor), a Canadian personal protective equipment mask manufacturer with an initial production facility located in Collingwood, Ontario on Saturday November 7th 2020. This binding LOI includes the initial purchase of ZEN's patent pending graphene based viricidal coating for a minimum of 100 million masks/filters with pricing of these mask/filters being variable based on a number of factors. This initial minimum order is for the first year and is subject to Health Canada approvals.
Nov 09, 2020 12:25 pm ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, Nov. 9, 2020 /CNW/ - Trading resumes in:
Nov 06, 2020 12:56 pm ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, Nov. 6, 2020 /CNW/ - The following issues have been halted by IIROC:
Oct 15, 2020 11:37 am ET
ZEN Graphene Solutions Announces New Research Collaboration Agreement on Carbon Aerogels with German Aerospace Center
Thunder Bay, Ontario--(Newsfile Corp. - October 15, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") today announced that it has signed a new research collaboration agreement with the Deutsches Zentrum für Luft- und Raumfahrt ("DLR", the German Aerospace Center) to investigate the use of Albany PureTM graphene-based nanomaterials in the fabrication of novel carbon aerogel composites. The goal of this collaborative research project titled, "Development of Innovative Composites based on Carbon Aerogels", is to develop electrode materials for new generation batteries and will build on the collaboration between ZEN, DLR and Dr. Lukas Bichler at the University of British Columbia‐Okanagan Campus (UBC-O) that was previously reported on October 15, 2018 and November 1, 2019.
Oct 09, 2020 04:01 pm ET
ZEN Graphene Solutions Signs 2 Year Extension with Chemisar Laboratories, Doubles Lab Space
Guelph, Ontario--(Newsfile Corp. - October 9, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to announce that it has signed a 2 year extension with Chemisar Laboratories Inc. ("Chemisar") to provide various consulting services which will include the use of 4,300 square feet of office and laboratory space in Guelph, Ontario commencing on January 1, 2021. The additional 2000 sq ft will be utilized to work on scale up effort for our patent pending Viricidal Coating manufacturing in response to the significant demand the company has received since announcing the patent filing on September 22, 2020.
Sep 30, 2020 08:00 am ET
Royal Canadian Navy Partners with ZEN Graphene and Evercloak to Test Graphene Oxide Dehumidification Membrane Technology
Thunder Bay, Ontario--(Newsfile Corp. - September 30, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce that the Naval Material Technology Management (NMTM) section of the Royal Canadian Navy (RCN) has partnered with ZEN and Evercloak Inc. (Evercloak) as a testing organization, and has agreed to provide in-kind donations of test services from the Naval Engineering Test Establishment (NETE). The tests will compare the efficiency of an HVAC unit produced with the Evercloak dehumidification membrane technology to the incumbent HVAC system that is currently in use on the RCN's Halifax-class frigates.
Sep 28, 2020 08:00 am ET
ZEN Graphene Solutions and Guelph University Researchers File Patent on Graphene Oxide Production Method - A Key Ingredient in its Virucidal Ink
Guelph, Ontario--(Newsfile Corp. - September 28, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) and (OTC: ZENYF) ("ZEN" or the "Company") is pleased to announce that the University of Guelph (Guelph) has filed a provisional patent regarding an electrochemical exfoliation (ECE) process to produce graphene oxide (GO) from Albany PureTM Graphite.
Sep 22, 2020 11:43 am ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, Sept. 22, 2020 /CNW/ - Trading resumes in:
Sep 22, 2020 11:22 am ET
ZEN Graphene Solutions Develops Graphene-Based Ink with 99% Virucidal Activity Against COVID-19
Guelph, Ontario--(Newsfile Corp. - September 22, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) ("ZEN" or the "Company") is pleased to report that after 5 months of optimization, it has developed a novel graphene-based virucidal ink with 99% effectiveness against COVID-19.
Sep 22, 2020 09:53 am ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, Sept. 22, 2020 /CNW/ - The following issues have been halted by IIROC:
Sep 22, 2020 08:30 am ET
ZEN Graphene Solutions Ltd. Announces COVID-19 Protocols for Annual Meeting of Shareholders
Thunder Bay, Ontario--(Newsfile Corp. - September 22, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") Shareholders are welcome to attend the Company's annual meeting of shareholders on September 28, 2020. Due to COVID-19 and its threats to the community we are required to follow new procedures at our upcoming annual meeting of shareholders. Those procedures are described below and were designed within the requirements laid out by public health authorities and the venue provider.
Sep 03, 2020 08:00 am ET
ZEN Graphene Solutions Provides Corporate Update
Thunder Bay, Ontario--(Newsfile Corp. - September 3, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to report that industry and university laboratories fully re-opened in late July-early August after a 4 month hiatus due to the Covid-19 pandemic and they have re-started ZEN's collaborative R&D programs. ZEN will report shortly on significant progress being made in multiple programs, one of which has resulted in the preparation of a patent filing that is central to ZEN's business plan.
Aug 06, 2020 08:00 am ET
Independent University Research Confirms and Quantifies Ease of Conversion of ZEN Graphene's Albany Pure(TM) Graphite to Graphene
Thunder Bay, Ontario--(Newsfile Corp. - August 6, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce that a recent peer reviewed research article clearly demonstrates that ZEN's Albany Graphite exfoliates more easily than other commercially available flake graphite test samples. Significantly, this article provides quantitative data that ZEN's Albany PureTM Graphite has the highest exfoliation rate constant of the materials tested, indicating that it exfoliates more easily than the other materials.
Jul 30, 2020 08:00 am ET
ZEN Begins Commercial Collaborations
Guelph, Ontario--(Newsfile Corp. - July 30, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN", or the "Company") is pleased to announce it has commenced collaborations with research teams at a number of personal protective equipment (PPE) manufacturers to incorporate ZEN's virucidal graphene ink into commercial products, including masks, gloves, gowns and other clothing following Zen's promising results for an antiviral, graphene-based ink formulation from The University of Western Ontario's ImPaKT Facility, biosafety Level 3 lab.
Jul 14, 2020 09:22 am ET
ZEN Graphene Solutions Engages Hybrid Financial Ltd.
Thunder Bay, Ontario--(Newsfile Corp. - July 14, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN", or the "Company") is pleased to announce that it has retained Hybrid Financial Ltd. ("Hybrid") to provide marketing services. Hybrid has been engaged to heighten market and brand awareness for ZEN Graphene Solutions and to broaden the Company's reach within the investment community.
Jul 09, 2020 08:00 am ET
ZEN Graphene Solutions Partners with Evercloak and NGen for Graphene in Cleantech Manufacturing Project
Thunder Bay, Ontario--(Newsfile Corp. - July 9, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce that Evercloak Inc. (Evercloak) and ZEN have been awarded $125,000 each as part of a Next Generation Manufacturing Canada (NGen) Project. The project entitled "Advancing Large-Scale Graphene and Thin-Film Membrane Manufacturing" will support the scale up of graphene oxide (GO) production by ZEN to supply GO to Evercloak for their scale up and optimizing activities. NGen supports collaborative technology projects that enable the development of world-leading advanced manufacturing capabilities in Canada.
Jul 06, 2020 04:02 pm ET
Zen Graphene Solutions Ltd. Completes Non-Brokered Private Placement of Units
Thunder Bay, Ontario--(Newsfile Corp. - July 6, 2020) - Zen Graphene Solutions Ltd. (TSXV: ZEN) ("Zen Graphene" or the "Company") is pleased to announce the closing of the second tranche, comprised of 1,621,175 units, of its previously announced private placement of units (the "Offering"). The Company raised total gross proceeds of $2,049,999.80 under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including graphene research and scale up, COVID-19 initiatives and other graphene applications development and for general corporate purposes. The Board of directors wishes to thank all the long-term shareholders and new shareholders who participated in the Offering.
Jun 29, 2020 08:09 am ET
Zen Graphene Solutions Ltd. Completes First Tranche of Non-Brokered Private Placement of Units
Thunder Bay, Ontario--(Newsfile Corp. - June 29, 2020) - Zen Graphene Solutions Ltd. (TSXV: ZEN) ("Zen Graphene" or the "Company") is pleased to announce the closing of the first tranche of its previously announced private placement of units (the "Offering"). The Company raised gross proceeds of $1,077,294.80 under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including graphene research and scale up, COVID-19 initiatives and other graphene applications development and for general corporate purposes. A second tranche is expected to close shortly in line with previous interest received and reported in the news release of June 17th 2020. The Board of directors wishes to thank all the long-term shareholders and new shareholders who participated in the Offering.
Jun 17, 2020 09:16 am ET
ZEN Graphene Solutions Ltd. Reports on Expressions of Interest for Non-Brokered Private Placements of Units
Thunder Bay, Ontario--(Newsfile Corp. - June 17, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce it has received expression of interest from investors in an amount of $1,777,000 for the non-brokered private placement (the "Offering") announced on June 15, 2020. These expressions of interest have far exceeded management's expectation and, subject to TSX Venture Exchange (the "Exchange") approval, the Company is working diligently to complete the Offering. Management believes that this highlights the progress ZEN has made in becoming an advanced materials graphene company. Following completion of the Offering, ZEN's cash balance will exceed any balance in recent years thereby ensuring the Company can continue executing its business plan during the COVID-19 pandemic. A subsequent news release will be issued concurrently with the closing of the Offering.
Jun 15, 2020 08:30 am ET
ZEN Graphene Solutions Ltd. Announces Non-Brokered Private Placement of Units
Thunder Bay, Ontario--(Newsfile Corp. - June 15, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") announces an offering of units (the "Units") of the Company on a non-brokered private placement basis. Each Unit is offered at a price of $0.60. The Offering is subject to TSX Venture Exchange (the "Exchange") approval.
Jun 11, 2020 05:00 pm ET
ZEN Graphene Solutions Announces First Results from Graphene Oxide Silver Nanoparticle Ink Formulations
Thunder Bay, Ontario--(Newsfile Corp. - June 11, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce it has received a report on the first batch of samples that were submitted to Western University's ImPaKT Facility Biosafety Level 3 lab (UWO) for virucidal efficacy testing. The batch-testing program's focus is to confirm and measure virucidal potency of the graphene oxide-based silver nanoparticle composite inks that were produced at ZEN's Guelph lab.
Jun 09, 2020 08:00 am ET
ZEN Graphene Solutions Announces Collaboration with UBC-O on Department of National Defence Project
Thunder Bay, Ontario--(Newsfile Corp. - June 9, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce it will be commencing a new research collaboration with Prof. Mohammad Arjmand and his team at the University of British Columbia (UBC)‐Okanagan Campus, with a $200,000 Department of National Defence (DND) Innovation for Defence Excellence and Security (IDEaS) award. ZEN will be providing in-kind contributions of Albany PureTM materials and consultation with its technical team.
Jun 08, 2020 02:02 pm ET
IIROC Trading Resumption - ZEN
VANCOUVER, BC, June 8, 2020 /CNW/ - Trading resumes in:
Jun 08, 2020 01:50 pm ET
ZEN Graphene Solutions Provides COVID-19 Response Update
Thunder Bay, Ontario--(Newsfile Corp. - June 8, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to report that it will be providing Albany PureTM Graphene Oxide produced by its Guelph facility for development of a rapid, ultrasensitive and low cost bio-sensor to detect the presence of the SARS-CoV-2 antigen and/or antibodies in COVID-19 suspected patients. This research is led by Prof. Maxim Berezovski, a full Professor at the University of Ottawa. Prof. Berezovski leads the Berezovski Research Group and the Bioanalytical and Molecular Interaction Laboratory. This research is funded by an initial grant of approximatively $400,000 from the National Sciences and Engineering Council (NSERC).
Jun 08, 2020 12:43 pm ET
IIROC Trading Halt - ZEN
VANCOUVER, BC, June 8, 2020 /CNW/ - The following issues have been halted by IIROC:
May 08, 2020 06:42 pm ET
ZEN Graphene Solutions Provides Corporate Update
Thunder Bay, Ontario--(Newsfile Corp. - May 8, 2020) -  ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") reports on the following corporate activities and agreements:
Apr 30, 2020 08:00 am ET
ZEN Graphene Solutions Announces Collaboration with Graphene Composites Ltd. to Develop a COVID-19 Virucidal Graphene-Based Composite Ink for Face Masks
Thunder Bay, Ontario--(Newsfile Corp. - April 30, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce an international collaboration with UK-based Graphene Composites Ltd (GC) to fight COVID-19 by developing a potential virucidal graphene-based composite ink that can be applied to fabrics including N95 face masks and other personal protective equipment (PPE) for significantly increased protection. Once the development, testing, and confirmation of the graphene ink's virucidal ability have been completed, the ink will then be incorporated into fabrics used for PPE.
Mar 26, 2020 08:00 am ET
ZEN Graphene Solutions Scaling up Graphene Production
Thunder Bay, Ontario--(Newsfile Corp. - March 26, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") has commenced scale-up and engineering studies on processes for the production of Albany Pure ™ Graphene products at the Company's research and development facility in Guelph, Ontario. The priority is to increase graphene production in anticipation of future demand as the Company launched graphene product sales in early March 2020. ZEN will also commission the recently purchased purification autoclave to commence the production of high-purity Albany graphene precursor material.
Mar 02, 2020 08:00 am ET
ZEN Graphene Solutions Announces the Launch of Graphene Product Sales
Thunder Bay, Ontario--(Newsfile Corp. - March 2, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) "ZEN" or the "Company") is pleased to announce the launch of Albany Pure TM graphene products on their website at https://shop.zengraphene.com/. The Company is planning to expand its product line to bring Graphene Quantum Dots, Graphene Oxide, Reduced Graphene Oxide, and other graphene-based products to the market.
Feb 04, 2020 04:02 pm ET
Zen Graphene Solutions Announces Grand Opening of Guelph Facility for Graphene Materials Production and Development
Thunder Bay, Ontario--(Newsfile Corp. - February 4, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce the grand opening of its Guelph facility on March 3, 2020. The facility will be used for small scale pilot plant production to produce future Albany Pure TM graphene products as well as further research and development work. All shareholders and interested parties are invited to attend. The Guelph facility is located at 24 Corporate Court, Guelph, Ontario. The opening will start at 1pm with an opportunity to meet with management, look at the lab facilities and attend a formal presentation at 3pm.
Feb 04, 2020 08:00 am ET
ZEN Graphene Solutions Announces Grand Opening of Guelph Facility
Thunder Bay, Ontario--(Newsfile Corp. - February 4, 2020) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce the grand opening of its Guelph facility for small scale pilot plant production and Research and Development.
Dec 20, 2019 08:00 am ET
ZEN Graphene Solutions Provides Corporate Update
Thunder Bay, Ontario--(Newsfile Corp. - December 20, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") has closed its previously announced private placement of flow-through common shares of the company and reports that it was oversubscribed. The company raised $1.21-million in respect of the offering, which will be used to finance the 2020 environmental baseline field program and community engagement work on the company's Albany graphite project.
Dec 10, 2019 08:00 am ET
ZEN Graphene Solutions Announces Offering of Flow-Through Shares
Thunder Bay, Ontario--(Newsfile Corp. - December 10, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") announces that subject to TSX Venture Exchange acceptance, it has arranged an offering of flow-through common shares of the company on a non-brokered private placement basis. The offering comprises up to 2.5 million flow-through common shares of the company at a price of 40 cents per flow-through common share for gross proceeds of up to $1-million. The proceeds from the offering will be used to continue work on the environmental assessment and for community engagement.
Nov 14, 2019 08:00 am ET
ZEN Graphene Solutions Reports on Multiple Intellectual Property Licensing Agreements
Thunder Bay, Ontario--(Newsfile Corp. - November 14, 2019) - ZEN Graphene Solutions Ltd. (TSXV:ZEN) ("ZEN" or the "Company")  has signed the definitive graphene manufacturing process License Agreement referred to in a news release on May 30, 2019. This agreement licenses to ZEN the intellectual property created by scientists and laboratories within a renowned Canadian University. This agreement has no expiry date and provides that a royalty is payable by ZEN based on the annual amount of material processed under the intellectual property.
Nov 01, 2019 08:00 am ET
ZEN Graphene Solutions Reports Preliminary Results for Graphene Aerogel Battery Tests
Thunder Bay, Ontario--(Newsfile Corp. - November 1, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") and its research partner, Deutsches Zentrum fur Luft- und Raumfahrt ("DLR", the German Aerospace Center) are pleased to report on additional encouraging results from their battery development program led by Dr. Lukas Bichler and his team at the University of British Columbia, Okanagan Campus (UBC-O). UBC-O has created a Graphene Aerogel composite anode material using a proprietary aerogel formulation containing doping with either ZEN's reduced Graphene Oxide (rGO) or Graphene (produced via ZEN's licensed process announced in the company's May 30, 2019 news release). Preliminary results indicate that relatively low loadings (<5 wt.%) of graphene-based material, combined with this proprietary aerogel structure, can result in an anode with a significant specific discharge capacity. Preliminary best results were achieved with a 2 wt.% loading of Graphene dispersed in aerogel and resulted in an initial specific discharge capacity of 2800 mAh/g and a discharge capacity of 1300 mAh/g after 50 cycles at a current capacity of 186 mA/g. These unoptimized results are believed to be better than those currently reported in the literature for Graphene Aerogel batteries. DLR and ZEN will present a poster of the battery results at the Batterieforum in Berlin, Germany in January 2020. Graphene-containing aerogels could have the potential to be a low-cost, low-weight, high-performance composite materials for near future energy storage applications.
Oct 01, 2019 08:14 am ET
ZEN Graphene Solutions Announces Encouraging Aluminum Metal Composite and Coating Results Using ZEN Graphene Material
Thunder Bay, Ontario--(Newsfile Corp. - October 1, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to announce additional research and development results using a ZEN Graphene additive in a sintered aluminium metal composite and ZEN Graphene in a corrosion-inhibiting coating.
Sep 27, 2019 07:29 am ET
ZEN Graphene Solutions Corporate Update
Thunder Bay, Ontario--(Newsfile Corp. - September 27, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company") is pleased to report on its recent activities including work on a novel electrochemical process for the production of 1-2 layer graphene oxide, graphite material processing and inventory plus encouraging preliminary results using reduced graphene oxide as a grain refinement additive for aluminum casting. The company is also pleased to announce that Mr. Greg Fenton has taken on a more active role in the day-to-day operations and has accepted the role of Chief Strategy Officer.
Sep 16, 2019 08:00 am ET
ZEN Graphene Solutions Signs Agreement with Chemisar Laboratories Inc. for Consulting and New Graphene Development Facility
Thunder Bay, Ontario--(Newsfile Corp. - September 16, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("ZEN" or the "Company")  is pleased to announce that it has signed an agreement with Chemisar Laboratories Inc. ("Chemisar") to provide various consulting services which will include the use of 2,300 square feet of office and laboratory space in Guelph, Ontario commencing on October 1, 2019. This office will become the company's new graphene research and development centre which will include a small-scale graphene processing and production facility. Additional space is available in the building which will allow ZEN to grow as needed.
Sep 12, 2019 04:35 pm ET
Zen Graphene Solutions Ltd. Completes Non-Brokered Private Placement of Units
THUNDER BAY, ON, Sept. 12, 2019 /CNW/ - Zen Graphene Solutions Ltd. ("Zen Graphene" or the "Company") (TSXV:ZEN) is pleased to announce the closing of its previously announced private placement (the "Offering"). The Company raised $1,050,000 under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including environmental studies, graphene research and development work, material processing and for general corporate purposes.  While the Company received significant demand for the Offering over the one million dollar initial target, it limited the Offering to $
Sep 03, 2019 08:00 am ET
ZEN Graphene Solutions Ltd. Announces Non-Brokered Private Placement of Units
Thunder Bay, Ontario--(Newsfile Corp. - September 3, 2019) - ZEN Graphene Solutions Ltd. (TSXV: ZEN) ("Zen Graphene" or the "Company") announces that it has arranged a non-brokered private placement financing to raise approximately $1.0 million (the "Offering") subject to regulatory approval. The Offering will consist of the sale of Units priced at $0.35 per Unit. Each Unit will be comprised of one Common Share and one-half of one non-transferable Common Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder to acquire one Common Share at a price of $0.50 for a period of 24 months from the date of issuance. All Warrants issued in connection with the Offering will be subject to an acceleration clause. If the Company's share price trades at or above $1.00 per share for a period of ten (10) consecutive trading days during the exercise period, the Company may accelerate the expiry date of the Warrants to 30 calendar days from the date on which a written notice is given by the Company to the Warrant holders. The proceeds of the Offering will be used to fund ongoing work on the Albany Graphite Project including environmental studies, graphene research and development work, material processing and for general corporate purposes.
Aug 08, 2019 08:00 am ET
ZEN Graphene Solutions Provides Grant Program and Environmental Baseline Study Update
Thunder Bay, Ontario--(Newsfile Corp. - August 8, 2019) -  ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) is pleased to provide an update on recent activities including the $1,000,000 reimbursement grant for graphene-Infused concrete applications research and progress on the environmental baseline study fieldwork.